Your browser doesn't support javascript.
loading
Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice.
Cathomas, Richard; Schardt, Julian; Pless, Miklos; Llado, Anna; Mach, Nicolas; Riklin, Christian; Haefeli, Jenny; Fear, Simon; Stenner, Frank.
Afiliação
  • Cathomas R; Department of Internal Medicine, Department of Oncology and Haematology, Kantonsspital Graubünden, Chur, Switzerland.
  • Schardt J; University Hospital for Medical Oncology, Inselspital Bern, Switzerland.
  • Pless M; Department of Medical Oncology, Kantonsspital Winterthur, Switzerland.
  • Llado A; Istitut Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
  • Mach N; Hôpitaux Universitaires Genève, Geneva, Switzerland.
  • Riklin C; Department of Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland.
  • Haefeli J; Roche (Schweiz) AG, Reinach, Switzerland.
  • Fear S; F Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Stenner F; Universitätsspital Basel, Basel, Switzerland.
Swiss Med Wkly ; 150: w20223, 2020 May 04.
Article em En | MEDLINE | ID: mdl-32399958

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Idioma: En Ano de publicação: 2020 Tipo de documento: Article